AXGN:NASDAQ
AxoGen, Inc Common Stock
49,60 USD
arrow_upward
+1,74%(+0,85) 1D
6-ноя., 12:05:44 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
48,55 USD
High
49,94 USD
Low
48,14 USD
Mkt. cap
2,96 млд
Avg. vol.
1,79 млн
Volume
213,13 миң
52-wk high
52,91 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
Open
48,55 USD
High
49,94 USD
Low
48,14 USD
Mkt. cap
2,96 млд
Avg. vol.
1,79 млн
Volume
213,13 миң
52-wk high
52,91 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
News stories
From web sources and news partners
Disruption Banking
·
44 мүнөт мурун
China Quant Funds Lose Over 10% as Nasdaq Rout Spreads
Fox Business
·
2 саат мурун
Nasdaq opens higher as chip stocks attempt to recover from brutal losses
TradingView
·
1 саат мурун
VIX Spikes Nearly 70%: History Says S&P 500 Usually Bounces Within a Month
Reuters
·
1 саат мурун
Nasdaq rebounds as chips stocks recover from steep losses
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersАлачуа, Флорида, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Websiteaxogeninc.com